Use Sonography in Patients With Intrauterine Device Presenting With Bleeding
Intrauterine Contraceptive Device:Clinical and Sonographic Correlation in Patients Presenting With Bleeding
1 other identifier
observational
60
0 countries
N/A
Brief Summary
Intrauterine contraceptive device is one of the most efficient and reversible methods of birth control with low cost and long duration of use However, in the first year after insertion, between 5 and 15% of women will have their Intrauterine contraceptive device removed because of irregular uterine bleeding which have been attributed to the effect of contact between the device and the endometrium and even the pressure on the uterine muscle . The disharmonious relationship between the Intrauterine contraceptive device and the uterus is the cause of most of the bleeding complaints, so bleeding is related to improper position rather than the contraceptive method itself which should be excluded before abandoning the Intrauterine contraceptive device for any other method of birth control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2017
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2017
CompletedFirst Posted
Study publicly available on registry
May 4, 2017
CompletedStudy Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedMay 4, 2017
May 1, 2017
1.2 years
May 3, 2017
May 3, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
The intrauterine device-Endometrial distance
3 months
Interventions
a method of contraception inserted in the uterus
Eligibility Criteria
patients using intrauterine contraceptive device complaining of bleeding
You may qualify if:
- patients using intrauterine contraceptive device complaining of bleeding
You may not qualify if:
- a-Associated uterine, cervical,or adenexal pathology b-Associated pelvic infection c-Generalized bleeding disorders d-Medications causing coagulation defects e-Medical disorders causing bleeding e.g hypertention f-Endocrine disorder as thyroid dysfunction g-Who refuse to share in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
May 3, 2017
First Posted
May 4, 2017
Study Start
June 1, 2017
Primary Completion
August 1, 2018
Study Completion
March 1, 2019
Last Updated
May 4, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share